NEW YORK (GenomeWeb News) — Genedata today said that Chugai Pharmaceuticals is using its Screener software to analyze high-throughput screening data.
Under the agreement, Genedata said its Tokyo-based staff has helped Chugai to integrate its AssayAnalyzer and Condoseo modules to review screening data and to evaluate compounds.
Genedata said Chugai has been using the software to help it develop drugs for cancer and for joint and bone diseases.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.